Keiji Hirata, Michael H. Nathanson  Gastroenterology 

Slides:



Advertisements
Similar presentations
It's time to bring the best and brightest back to gastroenterology!
Advertisements

Volume 122, Issue 2, Pages (February 2002)
Madhu Prasad, Jeffrey B. Matthews, Xue D. He, Hamid I. Akbarali 
The antithrombotic effect of aprotinin: actions mediated via the protease-activated receptor 1  Michael Poullis, FRCSa, Richard Manning, BScb, Mike Laffan,
Volume 114, Issue 3, Pages (March 1998)
Volume 117, Issue 4, Pages (October 1999)
Liver Transplantation: From Inception to Clinical Practice
Volume 122, Issue 2, Pages (February 2002)
The FXR-FGF19 Gut–Liver Axis as a Novel “Hepatostat”
Volume 133, Issue 5, Pages (November 2007)
Volume 119, Issue 6, Pages (December 2000)
Volume 121, Issue 5, Pages (November 2001)
Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: Endothelial dysfunction in portal hypertension  Don C. Rockey, John J. Chung 
Diagnosis of irritable bowel syndrome
Leptin, obesity, and liver disease
Volume 116, Issue 2, Pages (February 1999)
Volume 116, Issue 4, Pages (April 1999)
Volume 120, Issue 5, Pages (April 2001)
Na+-dependent fluid absorption in intact perfused rat colonic crypts
Volume 118, Issue 6, Pages (June 2000)
Volume 42, Issue 4, Pages (April 2005)
Psychiatric disorders among veterans with hepatitis C infection
Volume 124, Issue 1, Pages (January 2003)
Volume 124, Issue 1, Pages (January 2003)
Enteric glucagon 37 rather than pancreatic glucagon 29 stimulates glucose absorption in rat intestine  Frank Stümpel, Bettina Scholtka, Angela Hunger,
Hepatitis B infection in heart transplant recipients
Short-chain fatty acids have polarized effects on sodium transport and intracellular pH in rabbit proximal colon  Joseph H. Sellin, Roland De Soignie 
Volume 122, Issue 4, Pages (April 2002)
Permeability of the rat small intestinal epithelium along the villus-crypt axis: Effects of glucose transport  Britt–Marie Fihn, Anders Sjöqvist, Mats.
Loss of Inositol 1,4,5-trisphosphate receptors from bile duct epithelia is a common event in cholestasis  Kazunori Shibao, Keiji Hirata, Marie E Robert,
Effect of the two new calcium channel blockers mebudipine and dibudipine on vascular flow of isolated kidney of normal and diabetic rats  Lili Sepehr-Ara,
Arterioportal fistula in a child with biliary atresia
Volume 122, Issue 4, Pages (April 2002)
Nitric oxide and liver microcirculation during autoregulation and haemorrhagic shock in rabbit model  Lhuillier F , Robert M.-O. , Crova P , Goudable.
Volume 122, Issue 2, Pages (February 2002)
Lipid Rafts Establish Calcium Waves in Hepatocytes
Volume 121, Issue 2, Pages (August 2001)
Volume 120, Issue 4, Pages (March 2001)
Irshad Ali, Sushil K. Sarna  Gastroenterology 
Volume 122, Issue 2, Pages (February 2002)
Volume 131, Issue 3, Pages (September 2006)
Mitochondrial membrane perturbations in cholestasis
Alison M.J. Buchan, Paul E. Squires, Mark Ring, R.Mark Meloche 
Volume 123, Issue 1, Pages (July 2002)
Volume 122, Issue 4, Pages (April 2002)
Won Kyoo Cho, James L. Boyer  Gastroenterology 
Role of biliary phosphatidylcholine in bile acid protection and NSAID injury of the ileal mucosa in rats  Jose M. Barrios, Lenard M. Lichtenberger  Gastroenterology 
AGA technical review on nonalcoholic fatty liver disease
Volume 117, Issue 4, Pages (October 1999)
Volume 118, Issue 1, Pages (January 2000)
Antibody-mediated gastrointestinal dysmotility in scleroderma
Psychiatric disorders among veterans with hepatitis C infection
Domenico Alvaro, Alessandro Gigliozzi, Adolfo F. Attili 
Volume 119, Issue 6, Pages (December 2000)
Volume 119, Issue 4, Pages (October 2000)
Progression of fibrosis in chronic hepatitis C
Volume 64, Issue 1, Pages (January 2016)
Ca2+ waves require sequential activation of inositol trisphosphate receptors and ryanodine receptors in pancreatic acini  M.Fatima Leite, Angela D. Burgstahler,
AGA technical review on osteoporosis in gastrointestinal diseases
Volume 122, Issue 4, Pages (April 2002)
Volume 122, Issue 4, Pages (April 2002)
Reiner Wiest, Ming–Hung Tsai, Roberto J. Groszmann  Gastroenterology 
Jon B. Meddings, Ian Gibbons  Gastroenterology 
Regulation of cholangiocyte bile secretion
Volume 124, Issue 3, Pages (March 2003)
Volume 118, Issue 3, Pages (March 2000)
Hepatic oxygen supplementation as therapy in cirrhotic liver disease
Controversies in Liver Transplantation for Hepatitis C
Volume 120, Issue 4, Pages (March 2001)
Kinase activation and smooth muscle contraction in the presence and absence of calcium  Glenn Whitney, MD, Doug Throckmorton, MD, Carlos Isales, MD, Yo.
Presentation transcript:

Bile duct epithelia regulate biliary bicarbonate excretion in normal rat liver  Keiji Hirata, Michael H. Nathanson  Gastroenterology  Volume 121, Issue 2, Pages 396-406 (August 2001) DOI: 10.1053/gast.2001.26280 Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig.1 Secretin increases biliary bicarbonate concentration in a dose-dependent fashion.Secretin was infused via the hepatic artery in the isolated bivascularly perfused rat liver.Values here and in subsequent figures are means ± SD. Gastroenterology 2001 121, 396-406DOI: (10.1053/gast.2001.26280) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig.2 The effects of secretin on biliary bicarbonate concentration are attenuated when secretin is infused via the portal vein rather than the hepatic artery. Gastroenterology 2001 121, 396-406DOI: (10.1053/gast.2001.26280) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig.3 Dose-response curves for secretin-induced bicarbonate excretion.Data represent the net increase in bicarbonate concentration observed when secretin is administered via the hepatic artery (Figure 1) or the portal vein (Figure 2). Gastroenterology 2001 121, 396-406DOI: (10.1053/gast.2001.26280) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig.4 Effect of secretin on bile flow in the bivascularly perfused rat liver.Secretin does not affect the rate of bile flow when it is infused via either (A) the hepatic artery or (B) the portal vein. Gastroenterology 2001 121, 396-406DOI: (10.1053/gast.2001.26280) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig.5 ACh increases biliary bicarbonate concentration when it is infused via the hepatic artery but not the portal vein in the bivascularly perfused rat liver. Gastroenterology 2001 121, 396-406DOI: (10.1053/gast.2001.26280) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig.6 ACh transiently decreases bile flow regardless of whether it is infused via the hepatic artery or portal vein in the bivascularly perfused rat liver. Gastroenterology 2001 121, 396-406DOI: (10.1053/gast.2001.26280) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig.7 Effect of secretin plus ACh on biliary bicarbonate concentration.Secretin, ACh, or both were infused via the hepatic artery in the isolated bivascularly perfused rat liver.Simultaneous infusion of secretin (1 nmol/L) plus ACh (10 μmol/L) increased biliary bicarbonate concentration to the same extent as either agent alone.The tracings of secretin (1 nmol/L) or ACh (10 μmol/L) alone are from Figures 1 and 5. Gastroenterology 2001 121, 396-406DOI: (10.1053/gast.2001.26280) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig.8 Cyclosporin A does not alter the effects of secretin (1 nmol/L) plus ACh (10 μmol/L) on either (A) bicarbonate excretion or (B) bile flow.In each tracing, the agents are infused via the hepatic artery.The tracing of secretin plus ACh without cyclosporin A in A is from Figure 7. Gastroenterology 2001 121, 396-406DOI: (10.1053/gast.2001.26280) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig.9 Synergy between secretin (1 nmol/L) and ACh (10 μmol/L) depends on the order of administration.(A) ACh potentiates the effect of secretin on bicarbonate excretion, but only when secretin is administered first.(B) The synergistic effect of secretin plus ACh is blocked by cyclosporin A. Gastroenterology 2001 121, 396-406DOI: (10.1053/gast.2001.26280) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig.10 The effect of ACh (10 μmol/L) but not secretin (1 nmol/L) on bicarbonate excretion is inhibited by DIDS (100 μmol/L).(A) Direct comparison of the effects of DIDS, DIDS + ACh, and DIDS + secretin.Each agent was infused via the hepatic artery.(B) DIDS blocks ACh-induced bicarbonate excretion.ACh data from Figures 5 and 10A are replotted to show the change from baseline bicarbonate excretion when control data are subtracted at each time point.(C) DIDS has no effect on secretin-induced bicarbonate excretion.Secretin data from Figures 1 and 10A are replotted to show the change from baseline bicarbonate excretion when control data are subtracted at each time point. Gastroenterology 2001 121, 396-406DOI: (10.1053/gast.2001.26280) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig.11 DPC (100 μmol/L) inhibits the effect of both ACh (10 μmol/L) and secretin (1 nmol/L) on bicarbonate excretion.(A) Direct comparison of the effects of DPC, DPC + ACh, and DPC + secretin.Each agent was infused via the hepatic artery.(B) DPC blocks ACh-induced bicarbonate excretion.ACh data from Figures 5 and 11A are replotted to show the change from baseline bicarbonate excretion when control data are subtracted at each time point.(C) DPC inhibits but does not block secretin-induced bicarbonate excretion.Secretin data from Figures 1 and 11A are replotted to show the change from baseline bicarbonate excretion when control data are subtracted at each time point. Gastroenterology 2001 121, 396-406DOI: (10.1053/gast.2001.26280) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig.12 NPPB (50 μmol/L) inhibits the effect of both ACh (10 mmol/L) and secretin (1 nmol/L) on bicarbonate excretion.(A) Direct comparison of the effects of NPPB, NPPB + ACh, and NPPB + secretin.Each agent was infused via the hepatic artery.(B) NPPB blocks ACh-induced bicarbonate excretion.ACh data from Figures 5 and 12A are replotted to show the change from baseline bicarbonate excretion when control data are subtracted at each time point.(C) NPPB inhibits but does not block secretin-induced bicarbonate excretion.Secretin data from Figures 1 and 12A are replotted to show the change from baseline bicarbonate excretion when control data are subtracted at each time point. Gastroenterology 2001 121, 396-406DOI: (10.1053/gast.2001.26280) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig.13 Effects of glucagon and vasopressin on (A) bile flow and (B) biliary bicarbonate excretion in the isolated perfused rat liver.In these experiments, glucagon or vasopressin were infused via the portal vein, and the hepatic artery was not cannulated. Gastroenterology 2001 121, 396-406DOI: (10.1053/gast.2001.26280) Copyright © 2001 American Gastroenterological Association Terms and Conditions